home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Post navigation
Previous Post
Previous
ARVINAS ANNOUNCES INITIATION OF PATIENT DOSING IN THE FIRST PHASE 1 CLINICAL TRIAL OF PROTAC™ PROTEIN DEGRADER, ARV-110
Next Post
Next
Kura Oncology Announces Upcoming Presentations at AACR Annual Meeting 2018